Skip to main content
. 2021 Sep 30;21:1026. doi: 10.1186/s12879-021-06698-0

Table 1.

Clinical characteristics of the study patients

Overall CMV reactivation
N = 71 Yes (n = 13, 18.3%) No (n = 58, 81.7%) P
Age (yr) 64 ± 14 68 ± 12 63 ± 14 0.20
Gender, n (%) 0.37
 Male 58 (81.7) 9 (69.2) 49 (84.5) -
 Female 13 (18.3) 4 (30.8) 9 (15.5) -
 Height (cm) 168 (160–171) 160 (160–167) 168 (160–172) 0.10
 Weight (kg)a 58.5 ± 11.8 51.1 ± 10.6 61.6 ± 11.6 0.01
 BMI (kg/m2) a 21.3 ± 3.6 19.9 ± 4.1 22.1 ± 3.4 0.03
Severity of Score
 APACHE II 20 ± 7 22 ± 8 20 ± 7 0.37
 SOFA 8 (5–11) 8 (5–10) 8 (6–11) 0.80
Comorbidities, n (%)
 Hypertension 34 (47.9) 6 (46.2) 28 (48.3) 0.89
 COPD 28 (39.4) 6 (46.2) 22 (37.9) 0.58
 Coronary Heart Disease 19 (26.8) 4 (30.8) 15 (25.9) 0.99
 Diabetes 18 (25.4) 2 (15.4) 16 (27.6) 0.58
 Chronic Kidney Disease 6 (8.5%) 1 (7.7) 5 (8.6) NA
 Bronchiectasis 8 (11.3) 1 (7.7) 7 (12.1) NA
 Asthma 2 (2.8) 1 (7.7) 1 (1.7) 0.34
 Rheumatic Heart Disease 1 (1.4) 0 (0) 1 (1.7) NA
Complications, n (%)
 Surgical Factors 14 (19.7) 1 (7.7) 13 (22.4) 0.41
 Heart Surgery 13 (18.3) 1 (7.7) 12 (20.7) 0.49
 Trauma 1 (1.4) 0 (0) 1 (1.7) NA
 Internal Medicine Factors 57 (80.3) 12 (92.3) 45 (77.6) 0.41
 Severe Pneumonia 48 (67.6) 10 (76.9) 38 (65.5) 0.64
 AECOPD 25 (35.2) 5 (38.5) 20 (34.5) NA
 Sepsisa 18 (25.4) 7 (53.8) 11 (19.0) 0.02
 AKI 17 (23.9) 4 (30.8) 13 (22.4) 0.78
 Bronchiectasis Infection 8 (11.3) 1 (7.7) 7 (12.1) NA
 ARDS 7 (9.9) 3 (23.1) 4 (6.9) 0.21
 Asthma Exacerbation 3 (4.2) 1 (7.7) 2 (3.4) 0.46
 Acute Coronary Syndrome 3 (4.2) 0 (0) 3 (5.2) NA
 Heart Valve Disease 2 (2.8) 0 (0) 2 (3.4) NA
 Liver Failure 1 (1.4) 0 (0) 1 (1.7) NA
 Acute Suppurative Cholangitis 1 (1.4) 0 (0) 1 (1.7) NA

aP < 0.05; Continuous variables were expressed as Mean ± SD or Median (IQRs); Bold font indicates the difference was statistically significant. BMI Body Mass Index, APACHE II Acute Physiology and Chronic Health Evaluation, SOFA Sequential Organ Failure Assessment, COPD Chronic Obstructive Pulmonary Disease, AECOPD Acute Exacerbation of Chronic Obstructive Pulmonary Disease, AKI Acute Kidney Injury, ARDS Acute Respiratory Distress Syndrome